OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline incl...
Q1 2026
May 18, 2026
FY 2025
Mar 31, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 18, 2025